Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02097355 · ClinicalTrials.gov registry record · NA

Using an Online Patient Monitoring System to Improve Care for Children With Chronic Conditions

A NA study, sponsored by Boston Children's Hospital.

Completed
Registry status
NA
Development phase
946
Enrollment target

NCT02097355: Completed NA study, sponsored by Boston Children's Hospital.

NCT02097355 is a NA study that has completed, run by Boston Children's Hospital. The registered enrollment target is 946 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (33% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02097355, a NA study, has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
NA
Development phase
946 participants
Enrollment target

Study Summary

TriVox Health is an online system designed to make it easy for healthcare providers to monitor patients' disease symptoms and functioning over time and in between in-person visits (http://www.youtube.com/watch?v=VR1vcbx0Ef4). Using combined quality improvement and randomized clinical trial methods, we will evaluate the impact of TriVox on the health outcomes, patient/family experience of care, and healthcare utilization for children and adolescents with Attention Deficit Hyperactivity Disorder (ADHD), asthma, autism, depression, and epilepsy.

Primary Outcome

Caregiver-reported ratings on disease-specific symptom rating scale. For example, Vanderbilt ADHD Parent Rating Scale for ADHD; Asthma Control Test for asthma

Interventions

  • OTHER TriVox for clinical care

Trial Details

FieldValue
Enrollment Target 946 participants
Start Date 2014-12
Est. Completion 2019-12
Phase NA
Boston Children's Hospital

462 total trials

What the finished NCT02097355 record still lists

NCT02097355 is an interventional study that assigns participants to a tested intervention. The registered 946 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (33% lower).

The record links to 0 conditions, and to 1 intervention - of which TriVox for clinical care is the first listed.

NCT02097355 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02097355 about?

NCT02097355 is a clinical study titled "Using an Online Patient Monitoring System to Improve Care for Children With Chronic Conditions". TriVox Health is an online system designed to make it easy for healthcare providers to monitor patients' disease symptoms and functioning over time and in between in-person visits (http://www.youtube.com/watch?v=VR1vcbx0Ef4). Using combined quality improvement and randomized clinical trial methods, ...

What is the current status of trial NCT02097355?

This trial is currently completed. It is a NA study. The enrollment target is 946 participants. The study started on 2014-12. Estimated completion is 2019-12.

What interventions are being tested in trial NCT02097355?

The interventions under investigation include: TriVox for clinical care (OTHER).

Who is sponsoring clinical trial NCT02097355?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02097355's enrollment target sits among peer trials

946 123rd of 2000 higher than 1,878 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06087224 · 947 participants · NA

    The TELENEO Trial: A Multicenter Trial of Telemedicine for Advanced Neonatal Resuscitations in Community Hospitals

  • NCT05020236 · 944 participants · Phase 3

    A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

  • NCT04895709 · 949 participants · Phase 1

    A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors

  • NCT03784924 · 950 participants

    EDRN Prostate MRI Biomarker Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02097355, the US trial registry maintained by the National Library of Medicine. NCT02097355 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.